Use of tincture of opium compared to oral morphine for the treatment of neonatal abstinence syndrome

Suzannah Kokotajlo, Christine A. Robinson, Amy Presti

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: To evaluate the difference in time until medical clearance when comparing tincture of opium (TO) to oral morphine (OM) in the treatment of neonatal abstinence syndrome (NAS). Design: Retrospective chart review conducted from May 2007 to July 2011. Setting: Level III Neonatal Intensive Care unit at Morristown Medical Center in Morristown, New Jersey. Patients, Participants: Clinical Drug Utilization reports identified 26 neonates who were treated with TO and 25 neonates who were treated with OM for NAS. No patients were excluded. Interventions: Patients were treated with either TO or OM for the indication of NAS. Main Outcome Measure(s): The primary outcome is to compare the time it takes for a baby being treated with TO versus OM for NAS to be medically cleared for discharge. Results: The median time until medical clearance for those treated with TO was 29.5 days compared to 37 days for those treated with OM (p = 0.14). Conclusion: There was no statistically significant difference in the time it takes for a baby being treated with TO versus OM for NAS to be medically cleared for discharge. There are a number of safety benefits in using OM compared to TO. Until further data are collected, it is appropriate to continue treatment of neonates with NAS with OM.

Original languageEnglish (US)
Pages (from-to)62-70
Number of pages9
JournalJournal of Opioid Management
Volume9
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Neonatal Abstinence Syndrome
Opium
Morphine
Newborn Infant
Therapeutics
Drug Utilization
Neonatal Intensive Care Units
Outcome Assessment (Health Care)
Safety

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)
  • Anesthesiology and Pain Medicine

Cite this

@article{680a74c7bf6c412fbda9902a1598f04d,
title = "Use of tincture of opium compared to oral morphine for the treatment of neonatal abstinence syndrome",
abstract = "Objective: To evaluate the difference in time until medical clearance when comparing tincture of opium (TO) to oral morphine (OM) in the treatment of neonatal abstinence syndrome (NAS). Design: Retrospective chart review conducted from May 2007 to July 2011. Setting: Level III Neonatal Intensive Care unit at Morristown Medical Center in Morristown, New Jersey. Patients, Participants: Clinical Drug Utilization reports identified 26 neonates who were treated with TO and 25 neonates who were treated with OM for NAS. No patients were excluded. Interventions: Patients were treated with either TO or OM for the indication of NAS. Main Outcome Measure(s): The primary outcome is to compare the time it takes for a baby being treated with TO versus OM for NAS to be medically cleared for discharge. Results: The median time until medical clearance for those treated with TO was 29.5 days compared to 37 days for those treated with OM (p = 0.14). Conclusion: There was no statistically significant difference in the time it takes for a baby being treated with TO versus OM for NAS to be medically cleared for discharge. There are a number of safety benefits in using OM compared to TO. Until further data are collected, it is appropriate to continue treatment of neonates with NAS with OM.",
author = "Suzannah Kokotajlo and Robinson, {Christine A.} and Amy Presti",
year = "2013",
month = "1",
day = "1",
doi = "10.5055/jom.2013.0148",
language = "English (US)",
volume = "9",
pages = "62--70",
journal = "Journal of Opioid Management",
issn = "1551-7489",
publisher = "Weston Medical Publishing",
number = "1",

}

Use of tincture of opium compared to oral morphine for the treatment of neonatal abstinence syndrome. / Kokotajlo, Suzannah; Robinson, Christine A.; Presti, Amy.

In: Journal of Opioid Management, Vol. 9, No. 1, 01.01.2013, p. 62-70.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Use of tincture of opium compared to oral morphine for the treatment of neonatal abstinence syndrome

AU - Kokotajlo, Suzannah

AU - Robinson, Christine A.

AU - Presti, Amy

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Objective: To evaluate the difference in time until medical clearance when comparing tincture of opium (TO) to oral morphine (OM) in the treatment of neonatal abstinence syndrome (NAS). Design: Retrospective chart review conducted from May 2007 to July 2011. Setting: Level III Neonatal Intensive Care unit at Morristown Medical Center in Morristown, New Jersey. Patients, Participants: Clinical Drug Utilization reports identified 26 neonates who were treated with TO and 25 neonates who were treated with OM for NAS. No patients were excluded. Interventions: Patients were treated with either TO or OM for the indication of NAS. Main Outcome Measure(s): The primary outcome is to compare the time it takes for a baby being treated with TO versus OM for NAS to be medically cleared for discharge. Results: The median time until medical clearance for those treated with TO was 29.5 days compared to 37 days for those treated with OM (p = 0.14). Conclusion: There was no statistically significant difference in the time it takes for a baby being treated with TO versus OM for NAS to be medically cleared for discharge. There are a number of safety benefits in using OM compared to TO. Until further data are collected, it is appropriate to continue treatment of neonates with NAS with OM.

AB - Objective: To evaluate the difference in time until medical clearance when comparing tincture of opium (TO) to oral morphine (OM) in the treatment of neonatal abstinence syndrome (NAS). Design: Retrospective chart review conducted from May 2007 to July 2011. Setting: Level III Neonatal Intensive Care unit at Morristown Medical Center in Morristown, New Jersey. Patients, Participants: Clinical Drug Utilization reports identified 26 neonates who were treated with TO and 25 neonates who were treated with OM for NAS. No patients were excluded. Interventions: Patients were treated with either TO or OM for the indication of NAS. Main Outcome Measure(s): The primary outcome is to compare the time it takes for a baby being treated with TO versus OM for NAS to be medically cleared for discharge. Results: The median time until medical clearance for those treated with TO was 29.5 days compared to 37 days for those treated with OM (p = 0.14). Conclusion: There was no statistically significant difference in the time it takes for a baby being treated with TO versus OM for NAS to be medically cleared for discharge. There are a number of safety benefits in using OM compared to TO. Until further data are collected, it is appropriate to continue treatment of neonates with NAS with OM.

UR - http://www.scopus.com/inward/record.url?scp=84876086438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876086438&partnerID=8YFLogxK

U2 - 10.5055/jom.2013.0148

DO - 10.5055/jom.2013.0148

M3 - Article

C2 - 23709305

AN - SCOPUS:84876086438

VL - 9

SP - 62

EP - 70

JO - Journal of Opioid Management

JF - Journal of Opioid Management

SN - 1551-7489

IS - 1

ER -